GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink

scientific article

GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S1461145714000510
P932PMC publication ID4161658
P698PubMed publication ID24786948
P5875ResearchGate publication ID262023132

P50authorHoward TennenQ59975111
Henry R. KranzlerQ67465892
Jonathan CovaultQ96647614
Joel GelernterQ30032479
P2093author name stringStephen Armeli
Richard Feinn
P2860cites workUsing daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy studyQ44977108
The relationship between coping strategies, alcohol expectancies, drinking motives and drinking behaviourQ48155064
Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.Q50697707
Drinking habits and expectancies about alcohol's effects for self versus others.Q52279443
Relation of alcohol expectancies to changes in problem drinking among college students.Q53720898
Comprehensive effects of alcohol: Development and psychometric assessment of a new expectancy questionnaireQ56553453
Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanismQ95805364
An integrated map of genetic variation from 1,092 human genomesQ22122153
Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solutionQ24289449
Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkersQ24672412
Glutamatergic targets for new alcohol medicationsQ26824012
A general multilevel SEM framework for assessing multilevel mediationQ28292564
Topiramate blocks kainate-evoked cobalt influx into cultured neuronsQ28376946
Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neuronsQ28572670
Topiramate for treating alcohol dependence: a randomized controlled trialQ30444701
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trialQ30446318
Hierarchical modeling of sequential behavioral data: examining complex association patterns in mediation modelsQ31125453
A review of expectancy theory and alcohol consumptionQ31934361
Measurement of admixture proportions and description of admixture structure in different U.S. populationsQ33839183
The neurobiology of alcohol consumption and alcoholism: an integrative historyQ34378869
Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatmentQ36322822
The predictive validity of the Drinking-Related Cognitions Scale in alcohol-dependent patients under abstinence-oriented treatmentQ36367755
5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensityQ36625432
Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesityQ36999739
Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependenceQ37410610
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphismQ37719175
Development and initial validation of a measure of drinking urges in abstinent alcoholicsQ39474611
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory studyQ40131864
Do good things come to those who drink? A longitudinal investigation of drinking expectancies and hazardous alcohol use in female college athletesQ40305261
The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behaviorQ42685745
Alcohol expectancy and hazardous drinking: a 6-year longitudinal and nationwide study of medical doctorsQ43249032
Patterns of alcohol expectancies and alcohol use across age and genderQ44441824
Oral topiramate for treatment of alcohol dependence: a randomised controlled trialQ44454640
Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behaviorQ44853625
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonistQ44864684
Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neuronsQ44870767
P433issue10
P304page(s)1549-1556
P577publication date2014-04-30
P1433published inThe International Journal of NeuropsychopharmacologyQ7742309
P1476titleGRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink
P478volume17

Reverse relations

cites work (P2860)
Q93082377Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer's Disease Model Mice, APP/PS1
Q35553786Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments
Q26799837Ecological Momentary Assessment and Alcohol Use Disorder Treatment
Q47616594GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers
Q34609200GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate
Q38269776Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis
Q34643464Genetic variants of glutamate receptor gene family in Taiwanese Kawasaki disease children with coronary artery aneurysms
Q92354717Pharmacogenetics of alcohol addiction: current perspectives
Q34941610Posttreatment effects of topiramate treatment for heavy drinking.
Q35744334Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking
Q41468981The effects of single nucleotide polymorphisms in glutamatergic neurotransmission genes on neural response to alcohol cues and craving
Q51144124Using Ecological Momentary Assessment to Identify Mechanisms of Change: An Application From a Pharmacotherapy Trial With Adolescent Cannabis Users.
Q53414378Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.

Search more.